These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26764009)

  • 1. Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins.
    Chen CJ; Ermler ME; Tan GS; Krammer F; Palese P; Hai R
    J Virol; 2016 Jan; 90(7):3789-93. PubMed ID: 26764009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes.
    Hai R; Krammer F; Tan GS; Pica N; Eggink D; Maamary J; Margine I; Albrecht RA; Palese P
    J Virol; 2012 May; 86(10):5774-81. PubMed ID: 22398287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.
    Tran EE; Podolsky KA; Bartesaghi A; Kuybeda O; Grandinetti G; Wohlbold TJ; Tan GS; Nachbagauer R; Palese P; Krammer F; Subramaniam S
    mBio; 2016 Mar; 7(2):e00257. PubMed ID: 27006464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.
    Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y
    Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    Rajendran M; Sun W; Comella P; Nachbagauer R; Wohlbold TJ; Amanat F; Kirkpatrick E; Palese P; Krammer F
    PLoS One; 2018; 13(4):e0194830. PubMed ID: 29617394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B; Zhou H; Ye D; Kemble G; Jin H
    J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.
    Stech J; Garn H; Wegmann M; Wagner R; Klenk HD
    Nat Med; 2005 Jun; 11(6):683-9. PubMed ID: 15924146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris.
    Lin Q; Yang K; He F; Jiang J; Li T; Chen Z; Li R; Chen Y; Li S; Zhao Q; Xia N
    Appl Biochem Biotechnol; 2016 Aug; 179(7):1275-89. PubMed ID: 27040529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay.
    He W; Mullarkey CE; Miller MS
    Methods; 2015 Nov; 90():95-100. PubMed ID: 25957674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
    He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
    Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.
    Chen S; Zheng D; Li C; Zhang W; Xu W; Liu X; Fang F; Chen Z
    Biomed Res Int; 2015; 2015():901817. PubMed ID: 25767809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.
    Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA
    J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-only rescue of influenza A virus vaccine candidates.
    Schickli JH; Flandorfer A; Nakaya T; Martinez-Sobrido L; García-Sastre A; Palese P
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1965-73. PubMed ID: 11779399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective construction of DNA vaccines against variable influenza genes by homologous recombination.
    Ljungberg K; Wahren B; Almqvist J; Hinkula J; Linde A; Winberg G
    Virology; 2000 Mar; 268(2):244-50. PubMed ID: 10704333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice.
    Hu X; Meng W; Dong Z; Pan W; Sun C; Chen L
    Virus Res; 2011 Jan; 155(1):156-62. PubMed ID: 20883733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of eukaryotic expressing plasmids for HA and HA1 of influenza A virus and their transient expression in HEK293 cells].
    Zhang WD; Ca K; Li MY; Shi QF; Wang BN; Jiang ZH; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):176-9. PubMed ID: 16608068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Universal influenza vaccines: developments, prospects for use].
    Tsybalova LM; Kiselev OI
    Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.